The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Genmab A/S(NASDAQ:GMAB) 
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye d...
Website: http://www.genmab.com
Founded: 1999
Full Time Employees: 712
CEO: Jan G. J. van de Winkel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Genmab A/S Days Payable Outstanding ttm (DPO)
Genmab A/S Days Receivable Outstanding ttm (DSO)
Genmab A/S Days Inventory Outstanding ttm (DIO)
Genmab A/S Op Cashflow Per Share ttm
Genmab A/S Free Cashflow Per Share ttm
Genmab A/S Cash Per Share ttm
Genmab A/S P/S ratio ttm
Genmab A/S (GAAP) P/E ratio ttm
Genmab A/S P/B ratio ttm
No extra charts and metrics for this ticker.